Persistence and load of high-risk hpv are predictors for development of high-grade cervical lesions:: A longitudinal French cohort study

被引:336
作者
Dalstein, W
Riethmuller, D
Prétet, JL
Carval, KL
Sautière, JL
Carbillet, JP
Kantelip, B
Schaal, JP
Mougin, C
机构
[1] Ctr Hosp Univ, Hop Jean Minjoz, Cellular & Mol Biol Lab, Inst Etude & Transfert Genes, F-25030 Besancon, France
[2] Ctr Hosp Univ, Clin Univ Gynecol Obstet & Reprod, Besancon, France
[3] Ctr Hosp Univ, Anat Pathol Lab, Besancon, France
关键词
human papillomavirus (HPV); cervical cancer; cervical intraepithelial neoplasia; high-grade squamous intraepithelial lesions (HGSIL); Hybrid Capture II;
D O I
10.1002/ijc.11222
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oncogenic HPV types are the major cause of worldwide cervical cancer, but only a small proportion of infected women will develop high-grade cervical intraepithelial neoplasia or cancer (CIN2/3+). We performed a prospective study including 781 women with normal, atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LGSIL) cytology, and infected or not by high-risk (HR) HPV tested by Hybrid Capture II. Women were followed up every 6 months for a median period of 22 months. Among the HR-HPV-positive women at entry, more than half cleared their virus in 7.5 months; the clearance rate was greater for low viral loads than for high loads and also was higher in women with an initial ASCUS/LGSIL smear than in women with normal cytology. The incidence of cytologic abnormalities strongly depended on baseline viral load and HR-HPV persistence. Maintenance of cytologic abnormalities was associated with the outcome of HR-HPV status (negative<transient<persistent) but not with baseline load. Progression to CIN2/3+ was achieved only in women with persistent HR-HPV infection. The risk of CIN2/3+ also was increased with initial high loads (greater than or equal to100 pg/mL). Conversely, women who were consistently HR-HPV negative or transiently HR-HPV positive, whatever the cytology at baseline was, did not develop CIN2/3+ during follow-up. Age seemed to affect only the rate of incident HR-HPV infection. In conclusion, our data suggest that women repeatedly tested positive for HR-HPV are at risk of developing CIN2/3+, even when initial cytology is normal. A high viral load could be used as a short-term marker of progression toward precancerous lesions, although lower load does not inevitably exclude progressive disease. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:396 / 403
页数:8
相关论文
共 50 条
  • [1] USE OF SEMIQUANTITATIVE PCR FOR HUMAN PAPILLOMAVIRUS DNA TYPE-16 TO IDENTIFY WOMEN WITH HIGH-GRADE CERVICAL DISEASE IN A POPULATION PRESENTING WITH A MILDLY DYSKARYOTIC SMEAR REPORT
    BAVIN, PJ
    GILES, JA
    DEERY, A
    CROW, J
    GRIFFITHS, PD
    EMERY, VC
    WALKER, PG
    [J]. BRITISH JOURNAL OF CANCER, 1993, 67 (03) : 602 - 605
  • [2] Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: A longitudinal study of 3,091 women
    Bory, JP
    Cucherousset, J
    Lorenzato, M
    Gabriel, R
    Quereux, C
    Birembaut, P
    Clavel, C
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (05) : 519 - 525
  • [3] PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE
    BOSCH, FX
    MANOS, MM
    MUNOZ, N
    SHERMAN, M
    JANSEN, AM
    PETO, J
    SCHIFFMAN, MH
    MORENO, V
    KURMAN, R
    SHAH, KV
    ALIHONOU, E
    BAYO, S
    MOKHTAR, HC
    CHICAREON, S
    DAUDT, A
    DELOSRIOS, E
    GHADIRIAN, P
    KITINYA, JN
    KOULIBALY, M
    NGELANGEL, C
    TINTORE, LMP
    RIOSDALENZ, JL
    SARJADI
    SCHNEIDER, A
    TAFUR, L
    TEYSSIE, AR
    ROLON, PA
    TORROELLA, M
    TAPIA, AV
    WABINGA, HR
    ZATONSKI, W
    SYLLA, B
    VIZCAINO, P
    MAGNIN, D
    KALDOR, J
    GREER, C
    WHEELER, C
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11): : 796 - 802
  • [4] The causal relation between human papillomavirus and cervical cancer
    Bosch, FX
    Lorincz, A
    Muñoz, N
    Meijer, CJLM
    Shah, KV
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (04) : 244 - 265
  • [5] Broker T R, 2001, Dev Biol (Basel), V106, P443
  • [6] Cancer - Preventing cervical cancer
    Cain, JM
    Howett, MK
    [J]. SCIENCE, 2000, 288 (5472) : 1753 - 1754
  • [7] Human papillomavirus genotypes in rural Mozambique
    Castellsagué, X
    Menéndez, C
    Loscertales, MP
    Kornegay, JR
    dos Santos, F
    Gómez-Olivé, FX
    Lloveras, B
    Abarca, N
    Vaz, N
    Barreto, A
    Bosch, FX
    Alonso, P
    [J]. LANCET, 2001, 358 (9291) : 1429 - 1430
  • [8] Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible
    Castle, PE
    Lorincz, AT
    Mielzynska-Lohnas, I
    Scott, DR
    Glass, AG
    Sherman, ME
    Schussler, JE
    Schiffman, M
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) : 1088 - 1090
  • [9] Human papillomavirus detection by the hybrid capture II assay: A reliable test to select women with normal cervical smears at risk for developing cervical lesions
    Clavel, C
    Masure, M
    Levert, M
    Putaud, I
    Mangeonjean, C
    Lorenzato, M
    Nazeyrollas, P
    Gabriel, R
    Quereux, C
    Birembaut, P
    [J]. DIAGNOSTIC MOLECULAR PATHOLOGY, 2000, 9 (03) : 145 - 150
  • [10] HUMAN PAPILLOMAVIRUS TYPE-16 DNA IN CERVICAL SMEARS AS PREDICTOR OF HIGH-GRADE CERVICAL-CANCER
    CUZICK, J
    TERRY, G
    HO, L
    HOLLINGWORTH, T
    ANDERSON, M
    [J]. LANCET, 1992, 339 (8799) : 959 - 960